Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Assets (2016 - 2025)

Historic Return on Assets for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to 0.22%.

  • Niagen Bioscience's Return on Assets rose 1900.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 0.14% for FY2024, which is 2300.0% up from last year.
  • Latest data reveals that Niagen Bioscience reported Return on Assets of 0.22% as of Q3 2025, which was up 1900.0% from 0.21% recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Return on Assets ranged from a high of 0.22% in Q3 2025 and a low of 0.57% during Q2 2022
  • In the last 5 years, Niagen Bioscience's Return on Assets had a median value of 0.12% in 2023 and averaged 0.16%.
  • Its Return on Assets has fluctuated over the past 5 years, first plummeted by -500bps in 2022, then surged by 4100bps in 2023.
  • Niagen Bioscience's Return on Assets (Quarter) stood at 0.46% in 2021, then grew by 18bps to 0.37% in 2022, then skyrocketed by 75bps to 0.09% in 2023, then skyrocketed by 248bps to 0.14% in 2024, then surged by 57bps to 0.22% in 2025.
  • Its Return on Assets was 0.22% in Q3 2025, compared to 0.21% in Q2 2025 and 0.19% in Q1 2025.